ArticleCNS drugs2018

Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.

Mark Gudesblatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.